NCI-H209 is an immortal cell line derived from a bone marrow metastasis of a patient with small cell lung cancer, taken before chemotherapy. The specimen showed histologically typical small cells with classic neuroendocrine features. NCI-BL209 is an EBV-transformed B-cell line derived from the same patient as the small cell lung cancer cell line, NCI-H209

Request Access

Studies are experimental investigations of a particular phenomenon. e.g. case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients. Click on one of the Study IDs below to find out more.

Study ID Study Title Study Type
EGAS00000000051 Whole Genome Sequencing
ID File Type Size Located in Quality Control
EGAF50000036380 tar 31.6 GB
EGAF50000036381 5-kb-1_12_1.tar 70.8 GB
EGAF50000036382 tar 28.5 GB
EGAF50000036383 tar 53.3 GB
EGAF50000036384 tar 37.3 GB
EGAF50000036385 tar 37.7 GB
EGAF50000036386 tar 91.2 GB
EGAF50000036387 tar 38.2 GB
EGAF50000036388 tar 74.3 GB
EGAF50000036389 tar 47.2 GB
EGAF50000036390 tar 76.0 GB
EGAF50000036391 tar 35.5 GB
EGAF50000036392 tar 31.5 GB
EGAF50000036393 tar 59.4 GB
EGAF50000036394 tar 76.1 GB
EGAF50000036395 tar 62.2 GB
EGAF50000036396 tar 77.6 GB
EGAF50000036397 tar 43.2 GB
EGAF50000036398 tar 39.8 GB
EGAF50000036399 tar 82.4 GB
Request Access